The overarching purpose of this project is to advance our understanding ofthe influence of novel membrane associated steroid receptors on multiple phases of breast cancer progression. Progesterone is a key regulator of the membrane-associated steroid receptors and the importance of progesterone with respect to breast cancer etiology is highlighted by data from the Women's Health Initiative (WHl) randomized trials indicating that while use of combined estrogen and progestin menopausal hormone therapy (CHT) increases risk of breast cancer, use of estrogen alone does not. Dr. Li and his colleagues led the first of many subsequent studies to document that the risk of breast cancer associated with exogenous progestin use is primarily restricted to a more substantial increase in the risk of breast cancers of a lobular histologic type. However, the biological mechanisms underlying the strong relationship between progestin use and lobular breast cancer risk are essentially unknown. The findings from our population-based breast cancer studies (Drs. Porter and Li) and from in vitro studies in Dr. Ashley's laboratory identifying the presence and importance ofthe MPRs and CXCL12 and its receptor, CXCR4 in hormone-regulated reproductive pathways, lead us to hypothesize that both membrane associated receptors and metastatic chemoattractants, such as hormone-regulated CXCL12 and CXCR4, contribute to the differential impact of CHT use on risks and biology of lobular vs. ductal breast cancer. We plan to evaluate the contribution of membrane progesterone and estrogen receptor expression and downstream effects in relation to E+P use and histological subtype in well characterized ILC and IDC tumors from a large ongoing population-based study. Whole genome gene expression will be assessed in a subset of the lLC and IDC tumors to identify and characterize new factors and pathways relevant to the relationship between progesterone and breast cancer. This study will provide vital information relevant to breast cancer etiology and could lead to the identification of novel prevention and therapeutic targets. This project will also increase the capacity of NMSU to conduct competitive research through providing training on state ofthe art molecular techniques such as the DASL assay. Additionally, it partners a junior scientist. Dr. Ryan Ashley at NMSU, with two senior FHCRC scientists (Drs. Porter and Li) who will contribute directly to Dr. Ashley's career development.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Specialized Center--Cooperative Agreements (U54)
Project #
5U54CA132383-08
Application #
8926863
Study Section
Special Emphasis Panel (ZCA1)
Project Start
Project End
2016-08-31
Budget Start
2015-09-01
Budget End
2016-08-31
Support Year
8
Fiscal Year
2015
Total Cost
Indirect Cost
Name
New Mexico State University Las Cruces
Department
Type
DUNS #
173851965
City
Las Cruces
State
NM
Country
United States
Zip Code
88003
Ortega, Sigolène; McAlvain, Megan Stamey; Briant, Katherine J et al. (2018) Perspectives of Community Advisory Board Members in a Community-Academic Partnership. J Health Care Poor Underserved 29:1529-1543
Sanchez, N S; Quinn, K E; Ashley, A K et al. (2018) In the ovine pituitary, CXCR4 is localized in gonadotropes and somatotropes and increases with elevated serum progesterone. Domest Anim Endocrinol 62:88-97
Molina, Yamile; Briant, Katherine J; Sanchez, Janeth I et al. (2018) Knowledge and social engagement change in intention to be screened for colorectal cancer. Ethn Health 23:461-479
Gurley, Kay E; Ashley, Amanda K; Moser, Russell D et al. (2017) Synergy between Prkdc and Trp53 regulates stem cell proliferation and GI-ARS after irradiation. Cell Death Differ 24:1853-1860
Phan, Tuan Anh; Tian, Jianjun Paul (2017) The Role of the Innate Immune System in Oncolytic Virotherapy. Comput Math Methods Med 2017:6587258
Quinn, K E; Reynolds, L P; Grazul-Bilska, A T et al. (2016) Placental development during early pregnancy: Effects of embryo origin on expression of chemokine ligand twelve (CXCL12). Placenta 43:77-80
Salazar, Monica; Lerma-Ortiz, Alejandra; Hooks, Grace M et al. (2016) Progestin-mediated activation of MAPK and AKT in nuclear progesterone receptor negative breast epithelial cells: The role of membrane progesterone receptors. Gene 591:6-13
Adams, Scott V; Barrick, Brian; Christopher, Emily P et al. (2016) Urinary heavy metals in Hispanics 40-85 years old in Doña Ana County, New Mexico. Arch Environ Occup Health 71:338-346
Cao, Ruofan; Jenkins, Patrick; Peria, William et al. (2016) Phasor plotting with frequency-domain flow cytometry. Opt Express 24:14596-607
Qian, Lei; Bradford, Andrew M; Cooke, Peter H et al. (2016) Grb7 and Hax1 may colocalize partially to mitochondria in EGF-treated SKBR3 cells and their interaction can affect Caspase3 cleavage of Hax1. J Mol Recognit 29:318-33

Showing the most recent 10 out of 82 publications